CSN Chesnara plc
Chesnara plc, together with its subsidiaries, operates in life assurance and pension businesses primarily in the United Kingdom, Sweden, and the Netherlands. It underwrites life, health, accident, and disability cover by providing savings and pensions products to meet future financial needs; and provides a portfolio of investment contracts. The company also provides term life, unit-linked, index-linked, and non-linked business products. It distributes its products principally through independent financial advisers. Chesnara plc was incorporated in 2003 and is headquartered in Preston, the United Kingdom.…
Industry Peers
Insurance - LifeKey Statistics
About Chesnara (LON: CSN)
›
Chesnara (LON: CSN) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Insurance - Life industry, part of the Financial Services sector, and reports about 377 employees.
The shares were at 335.00 GBp on 19 November 2026, up 25.5% over 52 weeks.
At a market capitalisation of 775.36M GBP, it trades at 335.0 times trailing earnings and 14.7 times forward earnings. The median trailing P/E of its 19 largest Insurance - Life peers is 12.6, a premium of 2549% for CSN. It pays a dividend yielding 6.66%, against a median of 2.68% among the dividend payers in that peer group.
Chesnara reports return on equity of -1.8%, an operating margin of 17.6% and revenue up 70.9% year over year.
It holds more cash than debt, a net cash position of 16.21B GBP. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health. 5 analysts cover the stock, with an average rating of Buy; their mean price target of 391.00 GBp is 16.7% above the current price. The next earnings report is expected on 25 March 2027.